A Seeking Alpha opinion piece argues that Rocket Lab may be a buy after a sharp bout of weakness in the stock. The bullish case centers on the idea that RKLB shares have dropped even as the company continues to show progress in areas investors typically watch closely.
According to the article summary, supporters of the stock point to Iridium-related developments, defense contract wins and ongoing commercialization work tied to Neutron. That combination suggests the positive view is based on both near-term business momentum and a longer-term growth story rather than on market sentiment alone.
Neutron appears to be a major part of the investment thesis. Continued commercialization progress for the rocket is being treated as an important future driver for Rocket Lab, since a successful rollout could expand the company’s capabilities and strengthen its position in the space sector.
The source article is clearly framed as investment commentary, and the contributor disclosed a beneficial long position in RKLB. Even so, the takeaway is straightforward: some investors see the recent selloff in Rocket Lab stock as panic that may not fully reflect the company’s business wins and development milestones.
